Stock listing
BOATS:VOR Vor Biopharma Inc. Stock
US listing (BOATS) of Vor Biopharma Inc. · home listing NASDAQ:VOR
Follow Vor Biopharma Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:VOR
$19.25 USD -0.43 (-2.2%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:VOR
- Day range
- $18.84 – $20.00 USDNov 2, 2026
- Volume
- 624,085 sharesNov 2, 2026
- Market cap
- $1.14B USDAt the close on Nov 2, 2026 · price × 59.16M shares outstanding
- 52-week range
- $6.50 – $26.00 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $19.92M USDMedian day 800,400 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VOR · Home | $19.25 USD | -0.43 (-2.2%) | 624,085 | $19.71 | $20.00 | $18.84 | $19.68 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:VOR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $19.25 | -0.43 | -2.2% | $19.71 | $20.00 | $18.84 | 624,085 | |
| $19.68 | -1.23 | -5.9% | $19.91 | $20.47 | $19.37 | 759,293 | |
| $20.91 | +0.26 | +1.3% | $20.80 | $21.59 | $20.66 | 965,843 | |
| $20.65 | +1.11 | +5.7% | $19.50 | $20.81 | $19.38 | 1,011,532 | |
| $19.54 | +1.21 | +6.6% | $18.36 | $19.56 | $18.02 | 769,881 | |
| $18.33 | +0.07 | +0.4% | $18.33 | $18.44 | $17.70 | 470,337 | |
| $18.26 | -0.68 | -3.6% | $18.67 | $18.81 | $17.95 | 721,000 | |
| $18.94 | 0.00 | 0.0% | $18.87 | $19.44 | $18.65 | 722,400 | |
| $18.94 | -0.09 | -0.5% | $19.18 | $19.79 | $18.79 | 817,600 | |
| $19.03 | +0.99 | +5.5% | $18.06 | $19.55 | $18.00 | 796,000 | |
| $18.04 | +0.01 | +0.1% | $18.37 | $18.72 | $17.73 | 724,800 | |
| $18.03 | -1.31 | -6.8% | $19.45 | $19.45 | $18.00 | 733,100 | |
| $19.34 | +0.59 | +3.1% | $18.85 | $20.25 | $18.78 | 696,600 | |
| $18.75 | -0.31 | -1.6% | $18.79 | $19.74 | $18.55 | 926,900 | |
| $19.06 | -0.74 | -3.7% | $19.50 | $19.95 | $18.98 | 949,400 | |
| $19.80 | -0.10 | -0.5% | $19.79 | $20.52 | $19.55 | 867,400 | |
| $19.90 | +0.77 | +4.0% | $18.99 | $20.27 | $18.85 | 1,102,400 | |
| $19.13 | +0.35 | +1.9% | $18.64 | $19.88 | $18.08 | 1,406,600 | |
| $18.78 | +0.47 | +2.6% | $18.09 | $18.90 | $17.86 | 563,100 | |
| $18.31 | -0.27 | -1.5% | $18.85 | $18.87 | $17.97 | 472,800 | |
| $18.58 | -0.11 | -0.6% | $18.63 | $19.18 | $18.07 | 648,500 | |
| $18.69 | +0.63 | +3.5% | $18.09 | $18.99 | $18.09 | 773,300 | |
| $18.06 | -1.02 | -5.3% | $18.97 | $19.30 | $18.00 | 876,200 | |
| $19.08 | +0.75 | +4.1% | $18.54 | $19.81 | $18.38 | 1,069,900 | |
| $18.33 | +0.02 | +0.1% | $18.63 | $18.77 | $17.52 | 1,384,000 | |
| $18.31 | -0.21 | -1.1% | $18.36 | $18.74 | $18.02 | 930,100 | |
| $18.52 | +0.08 | +0.4% | $18.62 | $18.71 | $17.95 | 792,800 | |
| $18.44 | -0.93 | -4.8% | $19.02 | $19.37 | $17.55 | 1,931,500 | |
| $19.37 | -2.63 | -12.0% | $22.00 | $22.02 | $18.89 | 2,763,500 | |
| $22.00 | +0.11 | +0.5% | $21.83 | $23.82 | $21.61 | 2,586,500 | |
| $21.89 | +0.49 | +2.3% | $21.82 | $22.16 | $21.44 | 1,864,100 | |
| $21.40 | -0.49 | -2.2% | $21.92 | $22.00 | $21.23 | 3,725,700 | |
| $21.89 | -0.06 | -0.3% | $22.53 | $23.05 | $21.80 | 1,544,200 | |
| $21.95 | -0.37 | -1.7% | $22.39 | $22.52 | $21.81 | 1,496,400 | |
| $22.32 | -0.76 | -3.3% | $23.06 | $23.06 | $22.04 | 729,800 | |
| $23.08 | +0.78 | +3.5% | $22.39 | $23.56 | $22.27 | 886,100 | |
| $22.30 | -0.04 | -0.2% | $22.83 | $23.47 | $22.20 | 800,400 | |
| $22.34 | -0.895 | -3.9% | $22.96 | $23.09 | $22.09 | 689,300 | |
| $23.24 | -1.865 | -7.4% | $24.47 | $24.60 | $23.21 | 823,200 | |
| $25.10 | +0.05 | +0.2% | $24.75 | $26.00 | $24.10 | 856,700 | |
| $25.05 | +0.81 | +3.3% | $24.17 | $25.17 | $24.00 | 421,800 | |
| $24.24 | -0.52 | -2.1% | $24.80 | $24.94 | $23.88 | 538,800 | |
| $24.76 | +2.12 | +9.4% | $22.77 | $24.88 | $22.67 | 824,900 | |
| $22.64 | +0.16 | +0.7% | $22.32 | $22.88 | $22.05 | 607,300 | |
| $22.48 | -0.17 | -0.8% | $22.50 | $22.76 | $22.28 | 847,700 | |
| $22.65 | -0.88 | -3.7% | $23.20 | $23.29 | $22.38 | 491,100 | |
| $23.53 | -0.14 | -0.6% | $23.62 | $23.99 | $23.14 | 622,100 | |
| $23.67 | -0.34 | -1.4% | $23.68 | $24.09 | $23.39 | 446,700 | |
| $24.01 | +1.30 | +5.7% | $23.02 | $24.45 | $23.02 | 1,219,900 | |
| $22.71 | -0.65 | -2.8% | $23.12 | $23.18 | $21.90 | 500,000 | |
| $23.36 | +0.295 | +1.3% | $23.58 | $23.86 | $23.07 | 618,100 | |
| $23.07 | -0.515 | -2.2% | $23.05 | $23.41 | $22.79 | 649,600 | |
| $23.58 | +0.30 | +1.3% | $24.05 | $24.54 | $23.56 | 1,041,100 | |
| $23.28 | +0.27 | +1.2% | $22.82 | $23.85 | $22.62 | 1,006,900 | |
| $23.01 | -0.02 | -0.1% | $22.91 | $23.14 | $22.40 | 791,100 | |
| $23.03 | -0.26 | -1.1% | $23.33 | $23.35 | $22.38 | 417,600 | |
| $23.29 | +0.95 | +4.3% | $22.01 | $23.57 | $21.80 | 933,700 | |
| $22.34 | -1.25 | -5.3% | $23.48 | $23.51 | $21.75 | 992,200 | |
| $23.59 | +0.22 | +0.9% | $23.09 | $23.79 | $22.80 | 646,966 | |
| $23.37 | -0.30 | -1.3% | $23.35 | $23.84 | $22.95 | 602,111 | |
| $23.67 | -0.03 | -0.1% | $24.10 | $24.34 | $22.73 | 801,800 | |
| $23.70 | +1.43 | +6.4% | $22.01 | $23.79 | $21.90 | 735,200 | |
| $22.27 | +0.02 | +0.1% | $22.45 | $23.07 | $22.04 | 723,500 | |
| $22.25 | +0.84 | +3.9% | $21.55 | $22.49 | $21.51 | 834,900 | |
| $21.41 | +0.26 | +1.2% | $20.97 | $21.97 | $20.17 | 851,700 |
- Ticker
- BOATS:VOR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Vor Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Latest deck · Oct 2, 2026
American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting 2026
Conference · 13 slides
Latest news
Vor Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Oct 30, 2026
Closed $19.68 (-5.9%) on Oct 30, 2026
Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Nephropathy
Oct 22, 2026
Closed $18.26 (-3.6%) on Oct 23, 2026
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 5, 2026
Closed $18.31 (-1.5%) on Oct 6, 2026
Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis
Sep 8, 2026
Closed $25.10 (+0.2%) on Sep 8, 2026
Vor Bio To Participate in Upcoming September Conferences
Sep 1, 2026
Closed $22.64 (+0.7%) on Sep 1, 2026
Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 11, 2026
Closed $23.59 (+0.9%) on Aug 11, 2026
Vor Bio Appoints David Zaccardelli to Board of Directors
Jul 7, 2026
Closed $20.31 (+1.0%) on Jul 8, 2026
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China
Jun 8, 2026
Closed $13.29 (+1.0%) on Jun 8, 2026
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China
Jun 8, 2026
Closed $13.29 (+1.0%) on Jun 8, 2026
Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference
May 28, 2026
Closed $15.01 (-3.3%) on May 28, 2026
Financings
At-the-market programme of at-the-market sales
Aug 11, 2026
Closed: US$48.4M raised
Decks
American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting 2026
Conference · 13 slides · Oct 2, 2026
Investor Presentation (September 2026)
Investor deck · 60 slides · September 2026
44th Annual J.P. Morgan Healthcare Conference 2026
Conference · 19 slides · Jan 12, 2026
Technical Presentation (October 2025)
Technical · 29 slides · Oct 28, 2025
Vor Biopharma Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 27 in the last 12 months · 104 in all · newest Oct 30, 2026 · oldest 2021
- Decks
- 13 decks · latest Oct 2, 2026
Where Vor Biopharma Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VOR · Home listing | NASDAQ | United States | USD |
| BOATS:VOR · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Vor Biopharma Inc.